Please assess the completion status of the following clinical trial:

Trial Title: Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Inclusion Criteria~  * Subjects 18 years of age or older, all sexes and races~ * Willing to sign a written informed consent to participate~ * Corneal ulcer criteria: at least 3mm in diameter, opacification located within 3mm of visual axis, infiltrate occupying at least 50% of the corneal thickness, moderate AC cell reaction, clinical picture consistent with bacterial infection later confirmed by culture and gram stain.~Exclusion Criteria:~* History of Immunodeficiency~* History of connective tissue disorders or severe atopic disease~* History of chemical eye injuries~* History of known limbal stem cell deficiency~* History of neurotrophic keratopathy~* History of recent eye surgery, or glaucoma surgery with bleb or drainage tube~* Risk factors and clinical appearance consistent with fungal keratitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Conventional Treatment (Type: NO_INTERVENTION): * Corneal ulcer scraping sent for microbial culture~* Admission to the hospital for initiation of fortified vancomycin 25mg/mL every 1 hour alternating with fortified tobramycin 15mg/mL every 1 hour, preservative free artificial tears every 2 hours, and doxycycline 100mg twice daily.~After 48 hours of conventional treatment, consent will be obtained regarding the use of experimental treatment with ProKera Plus® versus continuing conventional method of treatment
- ProKera Plus® Treatment (Type: EXPERIMENTAL): 1. Experimental Treatment Arm , ProKera Plus® will be placed in the eye with the corneal ulcer

Based on this trial design, predict the completion outcome and termination type (if applicable).